The firm reported Q4 2014 revenues of $36.8 million, up from $32.7 million in Q4 2013, but falling short of analysts' average estimate of $41.9 million.
Baylor's clinical exome enhances coverage of over 3,600 genes and the lab has also validated Illumina's HiSeq X Ten for its research pipeline.
Elaine Mardis, co-director of the Genome Institute at Washington University in St. Louis, discussed genomic testing for cancer in both clinical research and diagnosis.
The company plans to bring both tissue-based and blood-based targeted sequencing tests through FDA clearance.
The companies are taking the CE-IVD route as opposed to the LDT model in the US due to Europe's distributed prenatal testing market and lower regulatory hurdles.
In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.
A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.
Researchers report that paternally inherited genes are more likely to be expressed in mice.
In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.